HIMS logo

HIMS
Hims & Hers Health Inc

56,593
Mkt Cap
$5.41B
Volume
14.78M
52W High
$70.43
52W Low
$13.74
PE Ratio
-289.99
HIMS Fundamentals
Price
$23.75
Prev Close
$24.01
Open
$24.09
50D MA
$24.25
Beta
2.23
Avg. Volume
33.46M
EPS (Annual)
$0.5123
P/B
12.28
Rev/Employee
$961,358.31
$8,927.84
Loading...
Loading...
News
all
press releases
Hims & Hers Deepens Personalized Care Through Platform Expansion
HIMS broadens beyond telehealth, adding labs, new hormone programs and global expansion as it builds a personalized care platform.
News Placeholder
More News
News Placeholder
HIMS Stock Extends 3-Day Rally: Hims & Hers Targets GLP-1 Gold Rush In Canada After Novo Nordisk Patent Expiry
The launch follows Novo Nordisk’s failure to pay a C$250 patent maintenance fee in Canada.
News Placeholder
Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform for eligible customers in Canada. This makes affordable GLP-1 treatment accessible to Canadians for whom cost has long been a barrier to...
News Placeholder
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide through its platform in Canada. This is Hims & Hers first international generic GLP-1 offering, demonstrating the companys ability to meet the unique needs of...
News Placeholder
Hims & Hers Stock Slips As Dilution Fears Outweigh New Capital
Hims & Hers Health is trading flat on Wednesday as the stock continues to digest financing-related dilution risk and positioning around its international expansion plans.read more...
News Placeholder
Is CAH Becoming the Backbone of US Healthcare Infrastructure?
Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare infrastructure.
News Placeholder
Nasdaq, S&P 500 Futures Lower As Markets Weigh Trump’s Iran Delay, Sticky Inflation Risks: Why NVDA, META, HD, HIMS Are Keeping Traders Engaged Today
Data from Stocktwits shows that despite the softer futures action, retail sentiment remained firmly bullish on SPY and QQQ.
News Placeholder
HIMS Stock Slips Overnight: Hims & Hers Bulks Up Debt Raise To $350M For Eucalyptus Buyout, AI Push
Hims priced $350 million of 0.00% convertible senior notes due 2032 and granted buyers an option to purchase an additional $52.5 million in notes.
News Placeholder
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
Hims & Hers Health, Inc. (Hims & Hers or the Company, NYSE: HIMS) today announced the pricing of its offering of $350 million aggregate principal amount of 0.00% convertible senior notes due 2032 (the notes) in a private offering to persons reasonably believed to be qualified institutional buyers...
News Placeholder
HIMS’ $300M Offering Gets Thumbs Up From Investors – Retail Shrugs Off Slide In Stock Price
The telehealth firm unveiled plans to raise $300 million through a private offering of convertible senior notes due 2032.
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available